BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 6843721)

  • 1. Evaluation of the LAI test in patients with benign and malignant breast diseases.
    Kovarík J; Lauerová L; Ninger E; Munzarová M; Feit J; Zemanová D; Wotke R
    Neoplasma; 1983; 30(2):163-7. PubMed ID: 6843721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-tumor immunity in breast cancer evaluated by a computerized tube leukocyte adherence inhibition (LAI) assay.
    Fink A; Shani A; Feldman B; Wechsler U; Pfeffermann R; Eliraz A; Offer S; Harpaz N; Bentwich Z
    Eur J Surg Oncol; 1989 Feb; 15(1):17-9. PubMed ID: 2645173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leukocyte adherence inhibition: tumor specificity of cellular and serum-blocking reactions in human melanoma, breast cancer, and colorectal cancer.
    Halliday WJ; Koppi TA; Khan JM; Davis NC
    J Natl Cancer Inst; 1980 Aug; 65(2):327-35. PubMed ID: 6157045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Study on the tumor immunity of renal cell carcinoma--with special reference to the significance of leukocyte adherence inhibition test].
    Okada Y
    Hinyokika Kiyo; 1984 Oct; 30(10):1367-77. PubMed ID: 6395679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunity to tumor-associated antigens in vasectomized men.
    Anderson DJ; Alexander NJ; Fulgham DL; Vandenbark AA; Burger DR
    J Natl Cancer Inst; 1982 Sep; 69(3):551-5. PubMed ID: 6180209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leukocyte adherence inhibition responses obtained with various tumor extracts in breast cancer patients.
    Kovarík J; Lauerová L; Feit J; Ninger E; Munzarová M; Zemanová D; Hlávková J
    Cancer Detect Prev; 1983; 6(1-2):215-9. PubMed ID: 6349799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specificity of tumor antigen recognition by T-lymphocytes in the leukocyte adherence inhibition (LAI) assay in patients with breast cancer.
    Tsang PH; Holland JF; Bekesi JG
    J Clin Lab Immunol; 1982 Dec; 9(3):151-7. PubMed ID: 6762442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Humoral antitumor immune responses in patients with breast cancer measured with the leukocyte adherence inhibition technique.
    Kotlar HK; Sanner T
    J Natl Cancer Inst; 1981 Feb; 66(2):265-71. PubMed ID: 7005505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blocking of the response by human T-lymphocytes to extracts of autologous cancer by monoclonal antibody to Class-I major histocompatibility complex gene products in the leukocyte adherence inhibition assay.
    Shenouda G; Thomson DM
    Cancer Res; 1984 Jul; 44(7):2762-8. PubMed ID: 6609766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Humoral leukocyte adherence inhibition (H-LAI) before and after surgery in human breast cancer.
    Horváth M; Tóth L; Tóth J; Fekete B
    Neoplasma; 1985; 32(5):623-7. PubMed ID: 3906415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Requirement for autologous cancer extracts and lipoxygenation of arachidonic acid for human T-cell responses in leukocyte adherence inhibition and transmembrane potential change assays.
    Shenouda G; Thomson DM; MacFarlane JK
    Cancer Res; 1984 Mar; 44(3):1238-45. PubMed ID: 6420056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early detection of breast cancer by leukocyte adherence inhibition assay.
    Sanner T; Kotlar HK; Eker P; Brennhovd I; Host H; Jorgensen O
    Cancer Detect Prev; 1983; 6(4-5):443-50. PubMed ID: 6360351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immunodiagnostic studies in ovarian cancer using the leukocyte adherence inhibition test (LAI test). 1. Detection of cellular sensitization of peripheral blood lymphocytes using the LAI test].
    Ludwig HJ; Storch H
    Zentralbl Gynakol; 1986; 108(10):593-606. PubMed ID: 3526755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell-mediated antitumor immunity in breast cancer patients evaluated by antigen-induced leukocyte adherence inhibition in test tubes.
    Grosser N; Thomson DM
    Cancer Res; 1975 Sep; 35(9):2571-9. PubMed ID: 1097110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leukocyte migration inhibition among breast cancer patients in response to various oncogenic viruses.
    Fukuda M; Wanebo HJ; Tsuei L; Ashikari R; Sarkar NH
    J Natl Cancer Inst; 1980 Mar; 64(3):431-7. PubMed ID: 6243720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Further study of specific immunoreactivity in patients with malignant melanoma of uveal tissue by LAI assay.
    Kalafut F; Cernák A
    Neoplasma; 1982; 29(5):561-6. PubMed ID: 7177245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leukocyte migration inhibition in relation to nuclear pleomorphism and lymphoid infiltration in breast cancer.
    Egami H; Sakamoto K; Kimura M; Nishimura R; Akagi M
    Jpn J Clin Oncol; 1985 Jun; 15(2):393-401. PubMed ID: 2410639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cellular antitumor immune response in women with risk factors for breast cancer.
    Sanner T; Brennhovd I; Christensen I; Jørgensen O; Kvaløy S
    Cancer Res; 1979 Feb; 39(2 Pt 2):654-7. PubMed ID: 761231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specific immunodiagnosis of hepatoma by tube leukocyte adherence inhibition assay and a modified method of repeated tube leukocyte adherence inhibition assay.
    Morizane T; Kumagai N; Tsuchimoto K; Watanabe T; Tsuchiya M
    Cancer Res; 1980 Aug; 40(8 Pt 1):2928-34. PubMed ID: 6248217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunologic characteristics of the leukocyte adherence inhibition assay in rheumatoid arthritis.
    Tannenbaum H; Wild J
    Clin Invest Med; 1983; 6(3):153-9. PubMed ID: 6360455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.